Skip to main content

Eisai

2022 Breast Cancer Guide to Patient Support Services

Eisai Reimbursement Resources

866-613-4724

Eisai offers drug-specific reimbursement assistance to patients taking Halaven (Table).

Eisai Reimbursement Resources

Eisai Reimbursement Resources offers a $0 Co-Pay Program and a Patient Assistance Program.

$0 Co-Pay Program

The $0 Co-Pay Program provides assistance for patients with commercial insurance who have been prescribed Halaven for an approved indication. The program is not available to patients enrolled in state or federal healthcare programs, including Medicare, Medicaid, Medigap, Veterans Administration, Department of Defense, or TRICARE.

Patient Assistance Program

Halaven may be available at low cost or no cost to financially needy patients who meet the program’s eligibility criteria, including US residency, income status, and site-of-service specifications. Coverage and payment depend on the patient’s insurance plan.

TABLE Eisai Breast Cancer Treatment

Drug
Indications
Patient support programs

Drug
Halaven (eribulin mesylate)
Indications
Treatment of metastatic breast cancer previously treated with at least 2 chemotherapeutic regimens. Prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting
Patient support programs